News

IRT Onco version is focused on tumor-specific immune response

InSysBio launches the Oncology version of Immune Response Template (IRT). IRT in Oncology represents a QSP platform of immune system in cancer, simultaneously being a tool for development of QSP and mechanistic models related to tumor-specific immune response.

InSysBio announces the start of operation of Headquarters in the United Kingdom. At the same time, the new branch office has been founded in Cyprus and part of InSysBio team has relocated there, thus, expanding the company’s presence.

InSysBio announces the creation of a new legal entity INSYSBIO CY Ltd. InSysBio continues the development of its QSP services and QSP tools infrastructure and contributing its experience to global research. Oleg Demin, CEO of InSysBio, comments on the significance and goals of this step.

Implementation of IRT equations into QSP projects becomes more facilitated

[Moscow – 20.01.2022] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launches Immune Response Template (IRT) version 3.6.0.

The launch of fIVE DB facilitates calibration of biomodels

InSysBio now presents its new QSP modeling tool, fIVE DB. The name of the database derives from In Vitro Experiments DataBase. fIVE DB is a repository of kinetic data for Systems Biology Modeling.

The new website represents InSysBio’s diverse expertise and corporate philosophy

InSysBio announces the launch of its new website. The aim of redesign was to fully represent all InSysBio’s diversified experience and to reflect the company’s current trend. The new website is more structured, user-friendly and provides more opportunities for feedback.